brensocatib

Italy

Drugs containing this active substance

  • BRINSUPRI

    It is used to treat patients aged 12 years and older with non-cystic fibrosis bronchiectasis (NCFB) who have had two or more exacerbations or worsening of symptoms in the previous 12 months.

    Form: tablets, film-coated

    Active substance Dosage
    brensocatib -

    ATC: R03

    Manufacturer: INSMED NETHERLANDS B.V.